Company / Operating Margin
Viridian Therapeutics, Inc.\DE Operating Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-5742.9%
FY2017
5-year range
-
FY2016-FY2017
Trend
-1075.5%
vs FY2016
Sector context
#132 of 136
Health Care
What the data says
Among 136 Health Care companies, Viridian Therapeutics, Inc.\DE is in the bottom 3% for operating margin.
Based on SEC 10-K filings.
-5742.9% in FY2017.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 136This company -5742.9% Sector average -778.9%
▼
-637.3% below sector average
Key checks
Key Insights
- In FY2017, operating margin decreased 1075.5% year-over-year.
- Currently 4963.9pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -5742.9% | -1075.5% |
| FY2016 | -488.6% | -149.2% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026